A population-based analysis of 6,857 patients with de novo metastatic colon cancer developed a nomogram to predict overall survival (OS) and cancer-specific survival (CSS). Key prognostic factors included histological grade, age, cancer stage, metastasis presence, perineural invasion, carcinoembryonic antigen levels, chemotherapy, and surgery. The nomogram showed a promising concordance index of 0.72, allowing for stratification into risk groups and providing personalized long-term survival probabilities for patients.
Journal Article by Wang R, Cheng J, Zhong W and Wang X in Ann Ital Chir